# Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.

> **NCT00752791** · PHASE2 · COMPLETED · sponsor: **Takeda** · enrollment: 59 (actual)

## Conditions studied

- Anemia

## Interventions

- **DRUG:** Peginesatide

## Key facts

- **NCT ID:** NCT00752791
- **Lead sponsor:** Takeda
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2012-08-15

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00752791

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00752791, "Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00752791. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*